Navigation Links
New choices for patients: Transfusion-free medicine for Jehovah's Witnesses and transfusion-wary
Date:12/5/2007

PHILADELPHIAJehovahs Witness patients no longer have to die for want of blood, says Patricia Ford, MD, a hematologist/oncologist and Medical Director of the Center for Bloodless Medicine and Surgery at Pennsylvania Hospital, part of the PENN Medicine hospital network. Dr. Ford is one of the pioneers of bloodless surgery and has been teaching its technique to doctors around the world.

One technique a bloodless surgery can employ is called cell salvage in which blood lost during surgery is siphoned from the body, passed through a filter for cleaning and returned to the body. It can also be used by the physician during surgery to limit blood loss and to avoid the need for transfusion of blood from sources other than the patient.

Jehovahs Witness patients believe that accepting blood from a source other then themselves defies the scriptural teachings that their religion holds steadfast. Originally developed to meet the needs of the Jehovahs Witness community, bloodless surgery is transfusion-free and is acceptable to Jehovah Witness followers because they are being reinfused with their own blood. Bloodless surgery and medicine is a viable and life-saving option for these patients and those wary of the safety of the blood supply, and it is safe for a growing number of surgical and medical conditions, except for acute leukemia and traumatic injury.

Bloodless procedures have proven to be safer than blood transfusion because they help eliminate complications resulting from transfusions such as immunosuppression, infection, diseases from emerging pathogens for which our blood supply is not yet tested, said Dr. Ford. The hospital stay is also shorter for our bloodless patients, a cost savings for the patient and the institution, she continues. Pennsylvania Hospital in Philadelphia is one of the pioneering centers for bloodless medicine and surgery.

Dr. Ford likens the weeks-old blood often used for transfusions to water from a dirty fish tank. Depleted of most of its oxygen-carrying capacity, the stored blood is not maximally beneficial to any patient.

Prior to surgery, Dr. Ford prepares patients carefully - using medicines to build red blood cells, and managing their hemoglobin count. A higher hemoglobin level lowers the risk of transfusion.

Dr. Ford has performed the largest number of successful stem cell transplants without blood transfusion of anyone in the world. Among the procedures for which Dr. Ford has prepared patients for bloodless medicine and surgery are cardiothoracic surgery; radical hysterectomies, prostatectomies, cystectomies, and repair of aneurysms, chemotherapy management, and total hip and knee surgery.

The bloodless team at Pennsylvania Hospital has saved the lives of many Jehovahs Witness patients who otherwise would not have received care. We see patients from all over the country who come to us for our expertise in bloodless medicine. The needs of the Jehovahs Witness community have helped us develop practices that can not only save their lives, but can also benefit the entire patient community, explained Dr. Ford.


'/>"/>

Contact: Lee-Ann Landis
landisl@uphs.upenn.edu
215-829-8043
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Grocery Shoppers Are Following Stars to More Nutritious Choices
2. FDA: Use the Nutrition Facts Label to Make Healthy Food Choices
3. ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices
4. New UIC center to study drug choices, safety
5. ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years
6. Video: New Web Site Helps Consumers and Employers Make Smart Choices on Health Savings Accounts (HSAs)
7. Angioplasty Equals Bypass Surgery for Heart Patients: Study
8. Care-ousel for Brain Tumor Patients: Doctors in the Hospital, Caregivers at Home
9. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
10. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: